This site is intended for Healthcare Professionals only.

Dulaglutide solution for pre-filled pens to remain out of stock until mid-April


Share post:

Supply of Dulaglutide, sold under the brand name Trulicity, 3mg/0.5ml and 4.5mg/0.5ml solution for injection pre-filled pens will remain out of stock until mid-April 2022.

This follows issuance of a Medicine Supply Notification (MSN) for the medication, used for the treatment of type 2 diabetes, by the Department of Health and Social Care (DHSC).

DHSC stated that Dulaglutide 0.75mg/0.5ml and 1.5mg/0.5ml solution are available and can support an uplift in demand.

In a separate notification, the department has notified MSN for Mesalazine (Asacol) 400mg and 800mg MR gastro-resistant tablets, which would remain out of stock until mid-March 2022.

It stated that Octasa MR 400mg and 800mg tablets are available and can support a full uplift in demand during this period.

In cases where Octasa MR tablets are not considered appropriate, other mesalazine tablets remain available to meet patients’ needs.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

FIP supports PDA’s Safer Pharmacies Charter

PDA urges all UK pharmacists to take part in the 2024 Safer Pharmacies Survey The International Pharmaceutical Federation...

Topiramate should not be prescribed for epilepsy during pregnancy unless…

MHRA tightens safety measures for topiramate by introducing a new pregnancy prevention programme  Healthcare professionals in the UK are...

WHO issues alert on fake copies of Novo Nordisk’s diabetes drug Ozempic

Falsified batches of Ozempic (semaglutide) were detected in Brazil, the UK, Northern Ireland and the United States The...

Synnovis cyber attack: NHS patient data leaked, services impacted

The NHS has set up helpline number to answer queries and concerns about patient data as Synnovis cyber...